Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Finch Therapeutics Group, Inc. (FNCH)
|
Add to portfolio |
|
|
|
| Price: |
$10.06
| | Metrics |
| OS: |
1.6
|
M
| |
|
|
| Market cap: |
$16.1
|
M
| |
|
|
|
Net cash:
|
$34.1
|
M
| |
$21.22
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($129)
|
M
| |
|
|
| EPS |
($6.23)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.9 | 18.5 | 7.7 | 10.2 |
| Revenue growth | -95.4% | 140.1% | -24.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 23.9 |
| Gross profit | 0.9 | 18.5 | 7.7 | -13.7 |
| Gross margin | 100.0% | 100.0% | 100.0% | -135.0% |
| Selling, general and administrative | 116.5 | 78.5 | 47.2 | |
| General and administrative | | | | 7.4 |
| EBIT | -95.6 | -56.3 | -39.2 | -21.1 |
| EBIT margin | -11108.2% | -304.0% | -508.4% | -208.2% |
| Pre-tax income | -114.6 | -58.2 | -39.3 | -20.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -114.6 | -58.2 | -39.3 | -20.8 |
| Net margin | -13315.4% | -313.8% | -509.7% | -204.4% |
| |
| Diluted EPS | ($2.40) | ($1.48) | ($4.83) | $0.00 |
| Shares outstanding (diluted) | 47.7 | 39.2 | 8.1 | 7,295.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|